Results

Total Results: 376 records

Showing results for "renal".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage renal … time since diagnosis), baseline RLS symptom severity and frequency, iron, pregnancy, and end-stage renal … psychiatric disorders, substance abuse disorders, or other serious medical conditions, including renal … • No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … We identified one other study in adults with RLS believed secondary to end-stage renal disease.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - The HAS-BLED scale (Hypertension, Abnormal renal/ liver function, Stroke, Bleeding history or predisposition … risk scores of interest due to unavailable data, such as genetic factors in HEMORR2HAGES (Hepatic or renal … Patients with renal impairment, with different INR control, and with prior stroke seem to benefit equally … large differences between demographics of study populations and community patients in terms of age, renal … Food and Drug Administration GWTG Get With The Guidelines HAS-BLED Hypertension, Abnormal renal/liver
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/home-dialysis-ESKD-rapid-research.pdf
    April 01, 2025 - currently affects more than 800,000 Americans, approximately 70 percent of whom are treated with renal … End stage renal disease and Medicare. Health Care Financ Rev. 2003; 24(4):1-5. PMID 14628396. 3. … The early history of dialysis for chronic renal failure in the United States: a view from Seattle. … Screening and supportive techniques for home dialysis in the treatment of renal failure. … Patients’ preferences regarding choice of end-stage renal disease treatment options.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
    February 23, 2012 - Published Online: February 23, 2012 3  Pneumonia, including pneumococcal vaccination  End-stage renal … coronary syndrome]; asthma, major depressive disorder asthma, cystic fibrosis, pneumonia, and end-stage renal …  Asthma  Cystic fibrosis  Pneumonia including pneumococcal vaccination  End-stage renal … depressive disorder; asthma; cystic fibrosis; pneumonia including pneumococcal vaccination; and end stage renal
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
    August 23, 2012 - evaluation for a variety of symptoms and laboratory abnormalities such as anemia, hypercalcemia, or renal … An increased FLC ratio without IgH positivity may also be associated with renal disorders and therefore … that 23% of patients with an increased FLC ratio without IgH positivity either have or will develop renal … as for MGUS) further workup with bone marrow examination with clonality testing, imaging studies, renal
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
    January 01, 2009 - , income level, race/ethnicity, and clinical subgroups (e.g., hypertensive/normotensive, diabetic, renal
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - amputation 2 People with diabetes often experience sev- eral associated medical complications, such as renal … The latter set of ICD-9 codes represents the following microvascular diseases: diabetic renal disease … Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
    November 20, 2013 - Rev 3 disc The decision to emphasize BMI and renal function as potential confounders of the diagnostic … The AHRQ report in 2006 identified both renal function and weight as potential physiological variables … high sensitivity C-reactive protein, N- terminal proBNP, and cardiac troponin T and I in end stage renal … If key data such as heart rhythm, body mass and renal function are not included then the model is not … Should be more emphasis on the key importance of heart rhythm along with adiposity and renal function
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
    July 26, 2012 - direct patient-centered outcome is clinically meaningful kidney damage (e.g. incident end stage renal … disease, progression to stage 4 CKD or worse, developing of acute renal failure requiring hospitalization … incident end stage renal disease, progression to stage 4 CKD or worse, developing of acute renal failure … Peer Reviewer #3 Discussion Using acute renal failure or end stage renal disease as outcomes is impractical … We do not know what causes stones to become detached and/or to pass and most non-obstructing renal
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
    March 10, 2010 - and consider dose reduction; limit to 10 mg once daily when used in combination with gemfibrozil • Renal … insufficiency statement: Rosuvastatin exposure is not influenced by mild to moderate renal impairment … , exposure to rosuvastatin is increased to a clinically significant extent in patients with severe renal … Please edit to reflect dosage adjustment is in patients with severe renal impairment. … Such patients are frail elderly, with small body size, and diminished renal and hepatic function.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
    January 01, 2011 - These data are consistent with the biologic’s indications for advanced renal cell carcinoma and hepatocellular … malignancy of other and unspecified sites (190.x to 199.x), indicative of their labeled use in advanced renal … Clearly, these biologics’ off-label use in renal cell carcinoma, chronic myelogenous leukemia, and metastatic
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Modulates hyperactive glutamatergic n-methyl-d-aspartate receptors Anxiety Diarrhea Vomiting Severe renal … a Dose adjustment for moderate renal impairment.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - and the potential influences of confounders such as age, ethnicity, and comorbidities (including renal … coronary artery disease (CAD), with CAD, other adults at risk of HF without documented HF (diabetes, renal … has been used to include or exclude subjects (e.g., acute coronary syndrome (ACS), CAD, Diabetes, Renal … hematocrit, widened QRS interval on 12-lead electrocardiogram, chronic hypotension, resting tachycardia, renal … widened QRS interval on 12-lead electrocardiogram, chronic hypotension, resting tachycardia, and renal
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
    May 29, 2025 - Reduced"effect"of"percutaneous" renal"denervation"on"blood"pressure"in"patients"with"isolated"systolic"hypertension … Blood"pressure"changes"after"renal"denervation"at"10"European"expert" centers." … "(2015)."4a.03:"Catheter' Based"Renal"Denervation"for"Resistant"Hypertension:"24"Month"Results"of"the"Enlightn"I … Eligibility"for"percutaneous" renal"denervation:"the"importance"of"a"systematic"screening." … Clinical(Outcomes( SOE:(Insufficient( ( One$quality$C$study$reported$ on$mortality$and$end"stage$ renal
  15. effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
    September 01, 2009 - Example: Randomized clinical trials studying the administration of hepatitis B vaccine to CRF [chronic renal … …Renal transplant patients were excluded from this review. Schroth RJ, et al. … Hepatitis B vaccination for patients with chromic renal failure. … Hepatitis B vaccination for patients with chromic renal failure. … Hepatitis B vaccination for patients with chromic renal failure.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
    March 15, 2016 - Renal stones were within scope, but no placebo-controlled treatment RCTs reported on this outcome. … We have modified the text on use in renal impairment. … , patients taking either febuxostat or allopurinol with mild renal impairment achieved higher rates … disease, and of intervening upon hyperuricemia demonstrating renal benefits. … However, we did examine our included studies for renal outcomes and added these to the text.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
    November 01, 2016 - regulation; medication adherence; or self-monitoring for diabetic complications (foot exam, eye exam, and renal
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
    May 01, 2011 - Serious adverse events such as myocardial infarction, stroke, and renal failure were either rarely reported
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - medications, nonsignificant results were observed for withdrawal due to adverse events, bleeding, renal … No statistically significant effects were observed in withdrawal due to adverse events, bleeding, renal … controlled or absent cholesterolemia and hypertension; no hx of diabetes, CVD, intervention, or renal … Adverse effects: No significant change in hepatic, thyroid, renal, or hematologic function. … No statistically significant effects were observed in withdrawal due to adverse events, bleeding, renal
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - For instance, biguanides such as metformin are contraindicated in patients with renal or liver failure … factors (e.g., race/ethnicity, age greater than 65 years, or gender) or comorbid conditions (e.g., renal … did not have enough information on subjects taking metformin with chronic conditions such as chronic renal … areas to focus on would be effects of medications in the elderly and in subjects with and without renal … based on demographic factors (e.g., race/ethnicity, age >65 years, or gender) or comorbidities (e.g., renal

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: